Navigation Links
Pelleve(TM) Wrinkle Treatment System Featured On 'Beauty Spaces' TV Show
Date:10/14/2009

OCEANSIDE, N.Y., Oct. 14 /PRNewswire/ -- Pelleve(TM), a skin tightening system for the nonsurgical treatment of wrinkles, will be seen in 120 million homes across the country this weekend on The Learning Channel's (TLC) "Beauty Spaces," a show that brings consumers the latest in beauty innovation and education. Created by the producers of the award-winning show "Designing Spaces," "Beauty Spaces" interviewed Dr. Michael Stampar to learn how Pelleve(TM) can help patients achieve a more youthful appearance with virtually no pain and little downtime.

The show airs nationally on TLC (Saturday at 7:00AM Eastern) and We(TM) (Friday at 7:30AM Eastern), as well as in Atlanta, Baltimore, Charlotte, Chicago, Dallas, Houston, Los Angeles, San Francisco and Tampa this week.

Dr. Michael Stampar, a board-certified facial plastic surgeon from Punta Gorda, Florida, demonstrated the Pelleve(TM) Wrinkle Treatment System with patients Linda Hendrick and Mimi Evans.

"Pelleve(TM) works by gradually and progressively heating the skin with a warming device to stimulate new collagen production, which results in the appearance of firmer skin," said Dr. Stampar. "Unlike other skin tightening procedures, Pelleve(TM) is virtually painless. Because we're raising the temperature of the skin gradually instead of suddenly, the patient experiences the feeling of a warm facial massage."

Stampar explained that immediately after the procedure, patients should expect to see skin that appears firmer and tighter. The overall result is a noticeable improvement in skin quality and appearance with minimal side effects and recovery time.

When asked who may be a candidate for Pelleve(TM), Dr. Stampar indicated that patients should speak to their physicians about whether Pelleve(TM) is appropriate for them based on their skin type, age, and what they hope to accomplish by having the procedure.

"The biggest advantage over other skin tightening procedures is that with Pelleve(TM), I can get a successful result every time," said Dr. Stampar. When asked what he'd like patients to know about the Pelleve(TM) Wrinkle Treatment System, Stampar replied, "Getting a Pelleve(TM) treatment turns back the clock on the aging process and may help slow the progression of facial wrinkles, folds and loose skin that can lead patients to seek surgery later."

"We're excited to bring the next generation of skin-tightening technology to a national audience," said Tom Harper, Executive Vice President of Global Marketing for Ellman International, which developed the Pelleve(TM) Wrinkle Treatment System. "The opportunity to be featured on We and TLC is a step forward for Pelleve(TM), as consumers have the chance to learn about the procedure and how it may help them achieve their aesthetic goals."

Pelleve(TM) was introduced to the U.S. market earlier this year through dermatologists, plastic surgeons, ENTs and other cosmetic surgery clinics.

To see Pelleve(TM) on "Beauty Spaces" via the web, visit www.designingspaces.tv.

For more information about Pelleve(TM) or to locate doctors trained in using the Pelleve(TM) Wrinkle Treatment System, visit www.pelleve.com or call 1-877-KNOW-PELLEVE.

About Ellman International

Established in 1959, Ellman International (Oceanside, New York) is a privately held manufacturer of medical devices used to perform a variety of aesthetic and surgical procedures. The company's products are based on patented and proprietary technologies utilizing high frequency radiowaves to perform precision electrosurgery and laser procedures in the medical, dental and veterinary specialties. For more information, please visit www.ellman.com

SOURCE Ellman International


'/>"/>
SOURCE Ellman International
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Pelleve Receives FDA Clearance for the Treatment of Mild to Moderate Facial Wrinkles
2. Isolagen, Inc. Submits Biologics License Application for the Treatment of Wrinkles to the U.S. Food and Drug Administration
3. Isolagen, Inc. Reports Positive Top-line Results from Pivotal Phase III Studies of Isolagen Therapy(TM) in Wrinkles: Studies Meet All Primary Efficacy Endpoints and are Statistically Significant
4. Isolagen Completes Pivotal Efficacy Portion of Phase III Studies of Isolagen Therapy(TM) for Wrinkles
5. Isolagen Inc. Completes Injections of Isolagen Therapy(TM) in Phase III Wrinkle and Phase II Full Face Studies
6. Curemark Enrolls First Patients in Phase III Clinical Trials for Autism Treatment
7. Eastern Europes First Novalis Tx(TM) Radiosurgery Platform Begins Radiotherapy Treatments in Latvia using RapidArc(R) Technology
8. ZyStor Therapeutics, Inc. Cleared to Begin Clinical Trial for Targeted Protein Therapeutic for the Treatment of Pompe Disease
9. Vanda Pharmaceuticals Enters into an Exclusive License Agreement for the Commercialization and Development of Fanapt(TM) in the U.S. and Canada for the Treatment of Schizophrenia
10. Metabolic Solutions Development Company To Test Potential Treatment for Alzheimers
11. CSL Behring Announces FDA Approval of Berinert(R), First and Only Therapy Approved for the Treatment of Acute Abdominal and Facial Attacks of Hereditary Angioedema in U.S.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... , Feb. 23, 2017 Report analyzes the ... provides separate comprehensive analytics for the US, Canada ... , Asia-Pacific , Latin ... forecasts are provided for the period 2015 through 2022. Also, ... data and analytics are derived from primary and secondary research. ...
(Date:2/24/2017)... , Feb. 23, 2017  Directors from Pharma To Market Pty ... have joined forces, resulting in the founding of Pharma To Market ... Pharma To Market are pleased to announce their expansion into ... Singapore . The company are delighted to appoint ... of the Singapore based entity. Joelle brings ...
(Date:2/24/2017)... Feb. 23, 2017  The particle counters market ... 2021 from USD 275.9 million in 2016, at ... full report: http://www.reportlinker.com/p04718602-summary/view-report.html The ... pharmaceutical R&D, and growth in manufacturing industries in ... growth for particle counters. On the other hand, ...
Breaking Medicine Technology:
(Date:2/24/2017)... ... February 24, 2017 , ... Only two months after ... Travel Market (ILTM) show in Cannes (France), XO Private has initiated a second print-run ... 420-page book measures almost a metre across when open, weighs in at more than ...
(Date:2/24/2017)... ... February 24, 2017 , ... Dr. Ronald E. ... announced the appointment of Peter A. Bell, DO, MBA, HPF, FACOEP-dist., FACEP, as ... beginning April 10. Dr. Bell comes to Liberty from the Ohio University Heritage ...
(Date:2/24/2017)... , ... February 24, 2017 , ... ... hearing disabilities, it is so critically important that we all are aware of ... is why Mediaplanet is proud to announce the launch of its newest edition ...
(Date:2/24/2017)... ... February 24, 2017 , ... With ProGlass Prism users now have the ... have total control over position, rotation, distortion, edge softness, edge blur, chromatic aberration, individual ... X. , With ProGlass Prism users are given the tools and effects to ...
(Date:2/24/2017)... ... February 24, 2017 , ... The International Association of Eating Disorders ... Beyond What You See” body image mannequin art competition. Selected from 15 submissions from ... the winner revealed at the 31st annual iaedp Symposium, March 22 – 26 in ...
Breaking Medicine News(10 mins):